Home

Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 25/10/30

Trade details

Type
Insider sale
Amount
$40,064
Shares · price
3,130 sh · $12.80 a share
Held after
43,876 sh
Trade date
25/10/30
Filed
25/10/30
Days to filing
0 days

Sold 6.7% of holdings

Share of holding sold
6.7%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/30~25/11/29

Hans van Houte's recent trades

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $110.6K

    Filed 08/04

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $223.4K

    Filed 05/05

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $9,999

    Filed 05/05

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $238K

    Filed 05/05

  • Hans van Houte

    SellNurix Therapeutics

    $39.8K

    Filed 04/30